"False"
Umeå universitet
printicon
Huvudmenyn dold.

Jonas Wallvik

Kontakt

E-post
jonas.wallvik@umu.se
Telefon

Verksam vid

Anknytning
Universitetslektor, överläkare vid Institutionen för folkhälsa och klinisk medicin Enhet: Avdelningen för medicin
Plats
1A, målpunkt B41, plan 4, Norrlands universitetssjukhus
IFNγ directly counteracts imatinib-induced apoptosis of primary human CD34+ CML stem/progenitor cells potentially through the upregulation of multiple key survival factors
Oncoimmunology, Taylor & Francis 2022, Vol. 11, (1)
Ujvari, Dorina; Malyukova, Alena; Zovko, Ana; et al.
Combination of tyrosine kinase inhibitors and the MCL1 inhibitor S63845 exerts synergistic antitumorigenic effects on CML cells
Cell Death and Disease, Springer Nature 2021, Vol. 12, (10)
Malyukova, Alena; Ujvari, Dorina; Yektaei-Karin, Elham; et al.
Montelukast, a cysteinyl leukotriene receptor antagonist, inhibits the growth of chronic myeloid leukemia cells through apoptosis
Oncology Reports, Vol. 40, (2) : 902-908
Zovko, Ana; Yektaei-Karin, Elham; Salamon, Daniel; et al.
Modulation of leukotriene signaling inhibiting cell growth in chronic myeloid leukemia
Leukemia and Lymphoma, Vol. 58, (8) : 1903-1913
Yektaei-Karin, Elham; Zovko, Ana; Nilsson, Anders; et al.
MODULATION OF LEUKOTRIENE SIGNALING INHIBITING CELL GROWTH IN CHRONIC MYELOID LEUKEMIA
Haematologica, Vol. 101 : 731-731
Yektaei-Karin, E.; Zovko, A.; Nilsson, A.; et al.
Second malignancies following treatment of chronic myeloid leukaemia in the tyrosine kinase inhibitor era
British Journal of Haematology, John Wiley & Sons 2015, Vol. 169, (5) : 683-688
Gunnarsson, Niklas; Stenke, Leif; Höglund, Martin; et al.
Modulation of Leukotriene Signaling Affecting Cell Growth in Chronic Myeloid Leukemia: A Key Pathway to Cure?
Blood, Vol. 126, (23)
Yektaei, Elham; Nilsson, Anders; Nasman-Glaser, Barbro; et al.
Second Malignancies Following Treatment of Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era
Blood, Vol. 124, (21)
Gunnarsson, Niklas; Leif, Stenke; Hoglund, Martin; et al.
Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia
Leukemia and Lymphoma, Informa Healthcare 2014, Vol. 55, (12) : 2769-2777
Mulligan, Stephen P; Karlsson, Karin; Strömberg, Mats; et al.
Visa publikationer i DiVA